Brief: Horizon Therapeutics Responds To U.S. Federal Trade Commission Action To Block Acquisition By Amgen
16/05/2023 18:34
May 16 (Reuters) - Horizon Therapeutics PLC HZNP.O :
* HORIZON THERAPEUTICS PLC RESPONDS TO U.S. FEDERAL TRADE
COMMISSION (FTC) ACTION TO BLOCK ACQUISITION BY AMGEN
* HORIZON THERAPEUTICS PLC - HORIZON DOES NOT AND HAS NO
PLANS TO
BUNDLE ANY OF ITS RARE DISEASE MEDICINES
* HORIZON THERAPEUTICS PLC: "FIRMLY BELIEVE" IN BENEFITS OF
AMGEN
ACQUISITION
* HORIZON THERAPEUTICS PLC: INTEND TO WORK WITH COURT ON A
SCHEDULE THAT WOULD ALLOW TRANSACTION TO CLOSE BY MID-DECEMBER
Source text for Eikon: ID:nBw3q1jXXa
Further company coverage: HZNP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Horizon Therapeutics
See all newsDeals of the day-Mergers and acquisitions
Amgen completes $27.8 bln Horizon deal (updated)
Amgen completes acquisition of Horizon Therapeutics
Brief: Amgen Completes Acquisition Of Horizon Therapeutics PLC
On October 5, Court Sanctioned The Scheme Of Arrangement Under Chapter 1 Of Part 9 Of The Irish Companies Act 2014